in Japan. CKD was classified according to newly established criteria derived from reference serum creatinine levels in Japanese children. Surveys were sent to 1190 institutions across Japan to report on cases of pediatric CKD managed as of 1 April 2010. Results. A total of 925 institutions (77.7%) responded. Information on 447 children was collected. When subdivided according to our diagnostic criteria, 70.5% of children had stage 3 CKD, 23.9% stage 4 and 5.6% stage 5. The estimated prevalence of Japanese children with CKD was 2.98 cases/100 000 children. Of 407 CKD cases with non-glomerular disease, 278 (68.3%) had congenital anomalies of the kidney and urinary tract (CAKUT). The newly established criteria showed good validity compared with existing criteria, including the abbreviated Schwartz equation. Conclusions. Findings from the first nationwide survey of predialysis CKD in Asian children indicate that the prevalence of stage 3-5 CKD in children in Japan aged 3 months to 15 years is 2.98 cases/100 000 children. Most children with CKD presented with non-glomerular disease, most frequently CAKUT. Improved management of CAKUT, including renoprotective treatment and urological intervention, is required.
I N T R O D U C T I O N
Chronic kidney disease (CKD) in children is a progressive and intractable condition, with devastating effects on the patient's growth, development and quality of life. If left untreated, pediatric CKD eventually progresses to end-stage renal disease (ESRD), which requires long-term dialysis or repeated renal transplantation. The mortality rate for children with ESRD on dialysis is estimated to be 30-150 times that of the general pediatric population [1, 2] . Therefore, it is particularly important to detect CKD as early as possible, possibly by applying simple but accurate screening of at-risk children. Early identification of these children can then allow the physician to promptly introduce appropriate therapy that can prevent or slow the progression of CKD to ESRD, reducing the incidence of stage 5 CKD and to control comorbidity.
Epidemiological information on CKD in children is currently limited, but this sort of information is necessary to understand the extent of the problem, to identify populations at risk and to determine the efficacy of current therapeutic interventions. Although several studies have described the epidemiology of pre-dialysis CKD in children in Western countries [3] [4] [5] [6] [7] [8] [9] [10] , very few have focused on Asian children. It is also important to consider that there may be differences in the epidemiology of CKD among countries that may be due to racial differences, variations in screening methods among medical institutions and differences in in-school screening programs. To address this problem of limited information in Asian children and to assist subsequent population-based surveys, we previously determined reference serum creatinine (SCr) levels in Japanese children [11] .
Our first objective in this study was to determine the prevalence of pre-dialysis CKD in a cross-sectional, nationwide survey of Japanese children aged 3 months to 15 years with pre-dialysis CKD. Stage 3-5 CKD was detected and classified using newly established criteria derived from normal SCr levels of age-and sex-matched Japanese children. Because CKD is defined as a glomerular filtration rate (GFR) of <60 mL/min/1.73 m 2 (less than half of normal GFR) in the Kidney Disease Outcomes Quality Initiative (K/DOQI) guidelines [12, 13] and the Kidney Disease: Improving Global Outcomes (KDIGO) position statement [14] (corresponding to stage 3 or worse), we focused on patients meeting this criterion and who had not yet received dialysis or renal transplantation. Our second objective was to determine the etiology of CKD as well as the method of detection of CKD and the treatment modalities used in routine clinical practice in Japan.
M AT E R I A L S A N D M E T H O D S
Establishment of new diagnostic criteria for CKD in children The new diagnostic criteria for stage 3-5 CKD were based on previously established reference SCr levels of Japanese children [11] . Briefly, in that study, body length and SCr levels were determined in 1151 healthy children aged 1 month to 18 years who presented at the facilities of the Committee of Measures for Pediatric CKD and Tokyo Health Service Association between 2008 and 2009. Reference intervals of SCr against age were calculated in children aged 3 months to 11 years, and those against age and sex were calculated in children aged 12-15 years.
According to the K/DOQI guidelines [12, 13] and KDIGO position statement [14] for CKD, stage 3-5 CKD was classified as GFR 30-59, 15-29 and <15 mL/min/1.73 m 2 , respectively (<1/2, <1/4 and <1/8 of normal GFR, respectively), whereas normal GFR was considered to be ∼120 mL/min/1.73 m 2 .
Given that the GFR is inversely proportional to SCr for a given body type and age [15] , we classified stage 3-5 CKD as SCr more than twice, four times and eight times, the median normal SCr levels matched for age alone in children aged 3 months to 11 years (Table 1) , or matched for age and sex in children aged 12-15 years (Table 2) .
Study design and population
This was a cross-sectional, nationwide, population-based survey conducted by the Pediatric CKD Study Group in Japan in conjunction with the Committee of Measures for Pediatric CKD of the Japanese Society for Pediatric Nephrology (JSPN). Two surveys were sent in August 2010 to a total of 1190 institutions in Japan, including all institutions that are members of the JSPN, all university and children's hospitals and all general hospitals with >200 beds, inviting them to report cases of pediatric CKD that were managed as of 1 April 2010. We selected these types of hospitals because children with apparent CKD were usually referred to institutions meeting one of these criteria. The deadlines for the first and second surveys were October 2010 and November 2010, respectively.
The first questionnaire was designed to record the presence and approximate number of children with stage 3-5 CKD in each institution. The second questionnaire recorded data for Values were matched for age alone. Values for the 2.5, 50 and 97.5th percentiles are as presented in Uemura et al. [11] . Table reproduced with the permission of the Japanese Society of Nephrology. Values were matched for age and sex. Values for the 2.5, 50 and 97.5th percentiles are as presented in Uemura et al. [11] . Table reproduced with the permission of the Japanese Society of Nephrology each case, including age, date of birth, sex, height, SCr level, primary renal diagnosis and associated diseases, method of detection, comorbidities and prescribed treatment. For the purpose of this survey, only data recorded within 6 months of 1 April 2010 were included. The patient's age was calculated from the date of birth and the date of each measurement. This questionnaire also recorded information for each institution, including the SCr assay method used, and prescribed treatment strategies. The respondents were asked to search their medical records for patients with a confirmed diagnosis of CKD or for patients with an abnormal SCr. The inclusion criteria were as follows: (i) children with CKD aged 3 months to 15 years at the time of 1 April 2010; (ii) stage 3-5 CKD, as determined by the newly established diagnostic criteria and (iii) no prior treatment with dialysis or renal transplantation. Only cases with kidney dysfunction that had lasted for >3 months were included and cases with transient increases in creatinine were excluded.
The study was conducted in accordance with the ethical principles set out in the Declaration of Helsinki, and with the ethical guidelines for epidemiological studies issued by the Ministry of Health, Labour and Welfare in Japan. The study was approved by the JSPN ethics board and a central ethics board (the institution of the Principal Investigator, KI) before study commencement. Because, data were reported retrospectively using patient charts, informed consent was not obtained in accordance with the above guidelines.
Statistical analyses
Estimation of the number of patients with stage 3-5 CKD in Japan from the reported number of patients in our survey was conducted as follows. The estimates were derived as the reported number divided by the response rate. Because the response rate tends to be lower in institutions with fewer patients, simple estimates can overestimate the true prevalence. Therefore, the reported patients were stratified according to institution type (i.e. university hospital, children's hospital and general hospital) and the number of beds (<200, 200-500 and ≥500), based on the assumption that the response rate is independent of the number of patients in each stratified category [16] . Then, the number of reported patients in each category was divided by the response rate and summed to calculate the total estimated number of patients in Japan. The total estimated number of patients was divided by the size of the population at risk in Japan reported by the Statistics Bureau of the Ministry of Internal Affairs and Communications of Japan (http://www.stat.go.jp/english/index.htm) to calculate the prevalence as of 1 April 2010. Weighted κ with 95% confidence interval (CI) was calculated to compare the CKD classification used here with the abbreviated Schwartz equation. All statistical analyses were carried out using SAS system version 9 (SAS Institute, Inc., Cary, NC, USA).
R E S U LT S

Subject characteristics
A total of 925 of 1190 institutions (77.7%) responded to the first questionnaire. A total of 479 children were identified in the second questionnaire. Of these, 447 children (272 males and 175 females) with stage 3-5 CKD who had not been treated with dialysis/renal transplantation fulfilled the eligibility criteria and were included in this study. Their characteristics are summarized in Table 3 . Most of the children (315; 70.5%) had stage 3 CKD, whereas 107 (23.9%) had stage 4 and 25 (5.6%) had stage 5. The number of Japanese children with stage 3-5 CKD was estimated to be 542.5 (95% CI: 497.5-587.5) as of 1 April 2010. On the basis of this, the prevalence of stage 3-5 CKD was calculated to be 2.98 cases/100 000 Japanese children aged 3 months to 15 years. Figure 1 shows the SCr values for males and females according to CKD stage. All of the responding institutions used enzyme immunoassays to determine SCr levels for the assessment of CKD stage; none used other methods, such as the Jaffe method. Figure 2 shows the frequencies of CKD stage according to the estimated GFR (eGFR) of 412 children in whom height was measured. Stage 3-5 CKD was classified using our diagnostic criteria derived from SCr levels of age-and sex-matched Japanese children, while the eGFR was determined using the abbreviated Schwartz equation, which was recently revised from the original Schwartz equation [17] . This figure also shows the distribution of children classified in each CKD stage determined using both methods. These data indicate that the distribution of CKD stages determined using populationbased reference values is comparable with the distribution derived using a method based on the abbreviated Schwartz equation. The weighted κ-value for this comparison was 0.71 (95% CI: 0.65-0.77). For 198 children with cystatin C data, similar distributions were obtained when we compared our new classification with the complete Schwartz equation, which requires cystatin C-values [17] (data not shown).
Primary etiologies of pediatric CKD in Japan
The primary etiologies of CKD in the study population are presented in Table 4 . Non-glomerular disease (407/447; 91.1%) was the most common primary cause of CKD, whereas glomerular disease accounted for 7.8% (35/447) of all cases.
Among those with non-glomerular diseases, 278 (68.3%) children had congenital anomalies of the kidney and urinary tract (CAKUT), of which 60 (21.6% of those with CAKUT) had obstructive urological malformations comprising posterior urethral valve, stricture of the urethra, hydronephrosis, hydroureter and cloacal anomaly ( Table 4 ). The three most common causes of glomerular diseases were Alport's syndrome, focal segmental glomerulosclerosis and chronic glomerulonephritis (n = 8 each). No children presented with definitively diagnosed IgA nephropathy. Figure 3 shows the distribution of CAKUT and non-CAKUT diseases by age.
The diseases included recognizable syndrome [n = 46 (10.3%)] as follows: Down syndrome (OMIN, #190685, n = 6); VATER association (#192350, n = 4); Kabuki syndrome (#147920); Wolf-Hirschhorn syndrome (#194190) and Townes-Brocks syndrome (#107480, n = 3 each); prune belly syndrome (#100100) and branchio-oto-renal syndrome (#113650, 2 each) and others. Table 5 summarizes the methods and reasons for the detection of children with stage 3-5 CKD. Table 5 also presents the age at diagnosis for each of the methods. Fetal and perinatal ultrasonography was the most common method, followed by analysis by chance and urinary tract infection. As might be expected, CKD was generally detected at an earlier age in children with CAKUT than in children with other forms of CKD, particularly for analysis by chance (3.9 versus 5.8 years), urinary tract infection (0.7 versus 1.8 years) and failure to thrive (0.3 versus 2.2 years). Annual urinalysis at school detected CKD in 27 children (9.7%; median age, 8.9 years) with CAKUT and 12 children (7.1%; median age, 8.3 years) with other forms of CKD.
Methods of detecting Stage 3-5 CKD
Treatment modalities for pediatric CKD
The treatment modalities for all patients included in this survey, and for patients with CAKUT and those with other forms of CKD, are summarized in Table 6 . The most common treatments for CAKUT were angiotensin II receptor blockers (ARBs) and angiotensin-converting enzyme inhibitors (ACEIs) which were used in approximately one-quarter of the patients. Both ARBs and ACEIs together were used in 11 and 23 patients with CAKUT and other forms of CKD, respectively (data not shown). Carbon adsorbents (e.g. AST-120), which F I G U R E 1 . Serum creatinine levels according to age and CKD stage. Actual serum creatinine levels according to age and CKD stage are plotted separately for males (A) and females (B).
are approved as renoprotective agents adsorbing uremic toxins in the gastrointestinal tract [18] and calcium antagonists, were used in 13.0 and 7.2% of patients, respectively.
D I S C U S S I O N
Our findings revealed that the prevalence of stage 3-5 CKD in children in Japan aged 3 months to 15 years is 2.98 cases/ 100 000 children. Out of 447 CKD cases surveyed, 407 (91.1%) had non-glomerular disease; among them, 278 (68.3%) had CAKUT. To our knowledge, this is the first cross-sectional, nationwide, population-based survey of children with pre-dialysis CKD in Asia. Several reports to date have described the epidemiology of pre-dialysis CKD in children; however, these studies were restricted to Western countries [3] [4] [5] [6] [7] [8] [9] [10] .
SCr levels were frequently used to estimate the GFR and screen for CKD. The original Schwartz equation has been used extensively in clinical practice for estimating the GFR in children, where GFR (mL/min/1.73 m 2 ) = age-dependent coefficient κ × height (cm)/SCr (mg/dL) [15] . This equation was recently modified because of the increasing use of enzymatic methods to determine SCr levels, replacing the Jaffe method [17] . However, there are some possible limitations of the original Schwartz equation. First, it requires the patient's height, which is not always measured in routine clinical practice. Secondly, the GFR was reported to be lower in Asian adults than in Caucasians [19] , which may have led us to overestimate the GFR when using the Schwartz equation in Asian children. To overcome these perceived limitations, several research groups have sought to establish reference levels in large populations of children [11, 20] , which may be more practical and relevant for screening purposes in a specific country. Accordingly, in F I G U R E 2 . Distribution of CKD stage in males and females. Stage 3-5 CKD was classified using our newly established diagnostic criteria derived from normal SCr levels of age-and sex-matched Japanese children. The eGFR was determined using the abbreviated Schwartz equation [17] . Stage 3-5 CKD was classified as GFR 30-59, 15-29 and <15 mL/min/1.73 m 2 , respectively (<1/2, <1/4 and <1/8 of normal GFR, respectively). Only subjects in whom height was measured were included in this analysis. Values in the table are n (%).
our present study, we evaluated renal function by comparison with established reference values [11] . In this way, CKD was determined based on SCr, rather than relying on equations adjusted for height and mathematical constants. As a result, children aged <2 years, to whom the normal CKD classification could not be applied, could be included. Similarly, Pottel et al. [20] proposed and validated a height-independent, population-normalized equation derived from the patient's SCr and the median SCr for age-matched healthy children. Based on their results, population-based reference levels for renal function and CKD may provide a valid approach to determine CKD stage for screening purposes, as in the present study. Indeed, our newly established CKD classification showed good validity compared with the abbreviated and complete Schwartz equations.
To classify stage 3-5 CKD, we used new diagnostic criteria based on previously determined SCr reference levels in ageand sex-matched Japanese children [11] . In that study, SCr was determined using enzymatic methods; in our current study, the participating institutes only used the enzymatic method to determine SCr. Therefore, our current results are not subject to confounding because of the use of multiple assay types.
The prevalence of pre-dialysis stage 3-5 CKD was estimated to be 2.98 cases/100 000 Japanese children, which was lower than that reported in the ItalKid and REPIR II Projects (7.47 and 7.106 cases/100 000 children, respectively). The reason for this lower prevalence of CKD in Japan in comparison with Western countries is unclear, but differences in the age of the cohort and the method of case definition may account for some of the difference. For example, the ItalKid Project [3] included children aged <20 years, used the original Schwartz equation to determine GFR and included children with eGFR <75 mL/min/1.73 m 2 . Similarly, the REPIR II Table 4 . Primary etiologies of stage 3-5 chronic kidney disease in Japanese children aged 3 months to 15 years 
O R I G I N A L A R T I C L E
P r e -d i a l y s i s p e d i a t r i c C K D i n J a p a n study [4] included children aged <19 years with stage 2 CKD, which accounted for 42% of their cases. Nevertheless, the estimated prevalence of stage 3-5 CKD in Spain, based on data from the REPIR II study, is 4.12 cases per 100 000 children (7.106 × 58%), which is slightly higher than that estimated in our study. The low frequency of pre-dialysis CKD in our study is consistent with the low frequency of children with ESRD in Japan [7] . A number of factors, such as differences in racial and ethnic distributions, primary cause of CKD and quality of medical care, may contribute to the difference in reported prevalence estimates between Japan and Western countries. Additionally, the prevalence of obstructive uropathy is low in Japan, being detected in just 21.6% of patients with CAKUT; by contrast, in Western countries, obstructive uropathy accounts for many cases of non-glomerular disease in children with CKD [21, 22] . Several factors may explain the differences in the prevalence of CAKUT with obstructive uropathy, including (i) genetic differences that affect the distribution of obstructive diseases (e.g. prune-belly syndrome) and (ii) the diagnosis of these congenital diseases may be difficult, resulting in underestimation of obstructive uropathies. However, despite the lower frequency of obstructive uropathy in Japan, appropriate urological interventions are still an indispensable part of the management of children with CKD, because they are one of very few treatments that can change the outcome of CKD [23] .
Despite the lower prevalence of CKD in our study compared with European cohorts, we believe that our data accurately represent the current situation in Japan because 1190 institutes, including all institutes belonging to the JSPN, were included in the survey and there was a very high response rate (77.7%). We also stratified institutions by hospital type and the number of beds to improve the accuracy of the estimated prevalence. Because the response rate tended to be lower for institutions with fewer patients, estimates of CKD prevalence that do not take strata (hospital size and type) into account are possibly overestimates. For example, a simple estimate without stratification in the present study would have been 599.0 children rather than the 542.5 estimated with strata taken into account. Thus, the stratified estimation method should correct for a bias between response rates and hospital type/size. Nevertheless, it is possible that some patients with stage 3-5 CKD were treated at other types of institutions not included in this survey. The majority of Japanese children with CKD presented with non-glomerular disease. CAKUT was the primary cause of CKD (i.e. 62.2% of all CKD cases). This observation was expected. Unlike in adults, in whom diabetes and hypertension are the primary cause of CKD, congenital causes are responsible for majority of pediatric CKD cases [1, 7] . The prevalence of CAKUT in our study is also consistent with that reported in the ItalKid and REPIR II studies (67.5 and 59%, respectively) [3, 4] .
Interestingly, there were very few cases of glomerular disease, such as focal segmental glomerulosclerosis, and no confirmed cases of IgA nephropathy (one case was suspected, but diagnosis was not confirmed). In a Japanese registry of pediatric ESRD patients conducted in 1998, 19% of patients had focal segmental glomerulosclerosis and 3% had IgA nephropathy [24] . The present analysis is likely to have underestimated the prevalence of these diseases for several reasons. First, these diseases progress more rapidly than nonglomerular diseases and could have been missed in the survey. Secondly, we restricted our analysis to those aged <16 years, but chronic glomerulonephritis frequently affects patients aged 16-20 years. Furthermore, these diseases respond well to novel treatment regimens that are well established in Japan, including combination therapy for IgA nephropathy [25] and cyclosporine in combination with steroids for steroid-resistant nephrotic syndrome, including focal segmental glomerulosclerosis [26] .
Fetal/neonatal ultrasonography was the most frequently used method to detect CAKUT, followed by blood analyses by chance and urinary tract infection. Only 27 children with CAKUT and 12 with other forms of CKD were detected following annual urinalysis at school. Patients with CKD, particularly children with CAKUT, do not necessarily show abnormal urinalysis, and are missed by the screening. It is also possible that CKD ( particularly non-CAKUT forms of CKD) could be detected in the earlier stages (earlier than stage 3) and patients could then receive appropriate intervention to treat the underlying disease. The treatment strategies for CAKUT and other forms of CKD in each institution were generally similar, although the responding institutions more often reported using carbon absorbents for CAKUT and ACEIs in other forms of CKD (data not shown). Some limitations of the study merit consideration. First, only 77.7% of the surveyed institutions responded to the questionnaire, which may limit the accuracy of the estimate. Secondly, although the classification system used for CKD staging in the present study was based on reference SCr levels determined via enzymatic methods from Japanese children, these diagnostic criteria have not been validated globally and other reference values would be needed for other populations. Height could have also been determined to estimate GFR via the Schwartz equation; however, because the GFR is inversely proportional to SCr in age-and sex-matched individuals, and because we used age-and sex-matched reference SCr levels established in a previous study with 1151 children, our measurements should be accurate enough and more practical for screening purposes. Indeed, our CKD staging showed good agreement with CKD staging based on the abbreviated Schwartz equation (Figure 2) . Because, our CKD staging method is based on the SCr level, CKD may be missed in children with small muscle mass, such as those with spina bifida, neuromuscular disease and short stature.
To our knowledge, this is the first nationwide, populationbased survey of children with pre-dialysis CKD in Asia and applied reference levels for CKD derived from a large cohort of Japanese children. This method showed good agreement with the abbreviated Schwartz equation and is practical for screening purposes, including children aged <2 years, as current methods are not appropriate for estimating CKD in this age group. The estimated prevalence of stage 3-5 CKD in Japan was 2.98 cases/100 000 children, which is lower than that in Western countries. Most cases presented with non-glomerular disease, and CAKUT was the most common cause of CKD. Improved management of CAKUT in children with CKD, including renoprotective treatment and urological interventions, is required. We are planning randomized and longitudinal studies to improve the management of pediatric CKD, and better understand its long-term prognosis. CAKUT, congenital anomalies of the kidney and urinary tract; CKD, chronic kidney disease; ARB, angiotensin II receptor blocker; ACEI, angiotensin-converting enzyme inhibitor; NA, not available.
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